Hip Reconstruction Devices Market

Key Players: Stryker (US), DePuy Synthes (US), Zimmer Biomet (US), Smith & Nephew (GB), Medtronic (US), B. Braun (DE), Exactech (US), Aesculap (DE), Wright Medical Group (US)

Hip Reconstruction Devices Market

Hip Reconstruction Devices Market Research Report: Size, Share, Trend Analysis By Product Type (Hip Implants, Hip Resurfacing Devices, Orthopedic Surgical Instruments, Bone Cement), By Material (Metal, Ceramic, Polyethylene, Composites), By Surgery Type (Total Hip Replacement, Partial Hip Replacement, Hip Revision Surgery), By End Users (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035
ID: MRFR/HC/14560-HCR
200 Pages
Vikita Thakur, Rahul Gotadki
Last Updated: May 15, 2026
Request Free Sample

Hip Reconstruction Devices Market Summary

As per Market Research Future analysis, the Hip Reconstruction Devices Market was estimated at 9.188 USD Billion in 2024. The Hip Reconstruction Devices industry is projected to grow from 9.832 USD Billion in 2025 to 19.34 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.0% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Hip Reconstruction Devices Market is poised for substantial growth driven by technological advancements and demographic shifts.

  • Minimally invasive techniques are gaining traction, enhancing patient recovery times and outcomes.
  • The integration of smart technologies into hip reconstruction devices is becoming increasingly prevalent, offering improved monitoring and functionality.
  • Personalized solutions are emerging as a focal point, catering to the unique needs of patients and enhancing satisfaction.
  • The rising incidence of hip disorders and the growing geriatric population are key drivers propelling market expansion, particularly in North America and the Asia-Pacific region.

Market Size & Forecast

2024 Market Size 9.188 (USD Billion)
2035 Market Size 19.34 (USD Billion)
CAGR (2025 - 2035) 7.0%

Major Players

Stryker (US), DePuy Synthes (US), Zimmer Biomet (US), Smith & Nephew (GB), Medtronic (US), B. Braun (DE), Exactech (US), Aesculap (DE), Wright Medical Group (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Hip Reconstruction Devices Market Trends

The Hip Reconstruction Devices Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing prevalence of hip-related disorders. The demand for innovative solutions is rising, as healthcare providers seek to enhance patient outcomes and improve surgical efficiency. This market appears to be characterized by a growing emphasis on minimally invasive procedures, which may lead to shorter recovery times and reduced hospital stays. Furthermore, the integration of smart technologies into hip reconstruction devices suggests a potential shift towards personalized treatment options, catering to the unique needs of individual patients. In addition, the aging population is likely to contribute to the expansion of the Hip Reconstruction Devices Market. As individuals age, the incidence of conditions such as osteoarthritis and fractures tends to increase, necessitating surgical interventions. This demographic trend indicates a sustained demand for hip reconstruction solutions. Moreover, ongoing research and development efforts are expected to yield novel materials and designs, which could enhance the durability and functionality of these devices. Overall, the Hip Reconstruction Devices Market appears poised for growth, driven by technological innovations and demographic shifts that underscore the need for effective hip reconstruction solutions.

Minimally Invasive Techniques

The trend towards minimally invasive surgical techniques is gaining traction within the Hip Reconstruction Devices Market. These approaches are designed to reduce tissue damage, leading to quicker recovery times and less postoperative pain. As surgeons become more adept at these techniques, the demand for devices that facilitate such procedures is likely to increase.

Integration of Smart Technologies

The incorporation of smart technologies into hip reconstruction devices is emerging as a notable trend. These innovations may include sensors and data analytics capabilities that allow for real-time monitoring of patient progress. Such advancements could enhance the overall effectiveness of hip surgeries and improve patient outcomes.

Focus on Personalized Solutions

There is a growing emphasis on personalized solutions within the Hip Reconstruction Devices Market. Tailoring devices to meet the specific anatomical and functional needs of individual patients appears to be a priority. This trend may lead to improved satisfaction rates and better long-term results for patients undergoing hip reconstruction.

Hip Reconstruction Devices Market Drivers

Growing Geriatric Population

The expanding geriatric population is a crucial factor driving the Hip Reconstruction Devices Market. As individuals age, the likelihood of developing hip-related ailments escalates, necessitating surgical interventions. By 2030, it is estimated that the number of people aged 65 and older will surpass 1 billion, significantly impacting healthcare systems worldwide. This demographic shift is likely to result in an increased demand for hip reconstruction surgeries, thereby boosting the market for related devices. Healthcare providers are increasingly focusing on addressing the needs of this population, which further emphasizes the relevance of the Hip Reconstruction Devices Market in contemporary healthcare.

Increased Healthcare Expenditure

Rising healthcare expenditure across various regions is fostering growth in the Hip Reconstruction Devices Market. Governments and private sectors are investing more in healthcare infrastructure, leading to improved access to surgical procedures and advanced medical technologies. Data suggests that healthcare spending is expected to grow at a compound annual growth rate of 5% over the next five years. This increase in funding allows for the procurement of state-of-the-art hip reconstruction devices, enhancing surgical capabilities and patient outcomes. Consequently, the financial commitment to healthcare is a pivotal driver of the Hip Reconstruction Devices Market.

Rising Incidence of Hip Disorders

The increasing prevalence of hip disorders, including osteoarthritis and hip fractures, is a primary driver of the Hip Reconstruction Devices Market. As populations age, the incidence of these conditions rises, leading to a greater demand for effective surgical interventions. According to recent data, the number of hip replacement surgeries is projected to reach approximately 3 million annually by 2030. This surge in surgical procedures necessitates advanced hip reconstruction devices, thereby propelling market growth. Furthermore, the growing awareness of treatment options among patients and healthcare providers contributes to the rising demand for innovative solutions in the Hip Reconstruction Devices Market.

Technological Advancements in Device Design

Technological innovations in the design and manufacturing of hip reconstruction devices are significantly influencing the Hip Reconstruction Devices Market. The introduction of advanced materials, such as biocompatible polymers and enhanced metal alloys, has improved the durability and performance of these devices. Additionally, the development of 3D printing technology allows for customized implants tailored to individual patient anatomies, enhancing surgical outcomes. Market data indicates that the adoption of these technologies is expected to increase, with a projected growth rate of over 8% in the next five years. This trend underscores the importance of continuous innovation in the Hip Reconstruction Devices Market.

Emphasis on Rehabilitation and Postoperative Care

The growing emphasis on rehabilitation and postoperative care is shaping the Hip Reconstruction Devices Market. Enhanced recovery protocols and rehabilitation programs are becoming integral to the surgical process, ensuring better patient outcomes and satisfaction. As healthcare providers recognize the importance of comprehensive care, there is a corresponding increase in the demand for devices that facilitate recovery. Market analysis indicates that the integration of rehabilitation technologies, such as wearable devices and telehealth solutions, is likely to expand, further driving the Hip Reconstruction Devices Market. This focus on holistic patient care underscores the evolving landscape of hip reconstruction.

Market Segment Insights

By Type: Hip Implants (Largest) vs. Hip Resurfacing Devices (Fastest-Growing)

The Hip Reconstruction Devices Market is characterized by a diverse array of products, with hip implants commanding the largest share due to their established presence and extensive use in orthopedic surgeries. This segment not only leads in adoption rates but also benefits from technological advancements and improved designs that enhance patient outcomes and surgical efficiency. Other product segments such as hip resurfacing devices and orthopedic surgical instruments also contribute to market dynamics, albeit at a smaller scale compared to hip implants.

Hip Implants (Dominant) vs. Hip Resurfacing Devices (Emerging)

Hip implants are the dominant force in the Hip Reconstruction Devices Market, widely recognized for their reliability and effectiveness in restoring hip function. They include total hip replacements and partial implants, which cater to varying degrees of hip degradation and patient needs. On the other hand, hip resurfacing devices are gaining traction as an emerging alternative, particularly among younger and more active patients due to their bone-conserving procedures. These devices allow for less invasive interventions, fostering quicker recovery times and improved mobility, positioning them as a significant area of growth within the market.

By Material: Metal (Largest) vs. Ceramic (Fastest-Growing)

The hip reconstruction devices market showcases a diverse range of materials, where Metals dominate due to their strength and durability, making them the preferred choice for a significant portion of surgeries. Ceramic materials, on the other hand, are experiencing rapid acceptance due to their excellent wear resistance and biocompatibility, allowing them to capture a growing share of the market as surgeons increasingly favor options that reduce friction and improve patient outcomes. As the demand for hip reconstruction continues to grow, the emphasis on patient safety and recovery has led to a shift towards advanced materials like ceramics. Their properties, coupled with ongoing research and technological advances, are propelling their growth, while Metals maintain a stronghold due to their established reliability. The evolving preferences of healthcare practitioners and patients alike are driving innovation in the material segment, making it an exciting area for future developments.

Metal: Dominant vs. Ceramic: Emerging

In the hip reconstruction devices market, Metal stands as the dominant material, favored for its robustness and longevity, ideal for load-bearing implants. It is commonly associated with traditional hip replacements and has a long history of successful outcomes, which reinforces its market leadership. Meanwhile, Ceramic is viewed as an emerging competitor, gaining traction due to its lower friction coefficients and resistance to wear, which translates to longer-lasting implants. Its growing popularity comes amid increasing focus on minimizing wear-related complications in patients. With advancements in ceramic technology enhancing its performance and acceptance among orthopedic surgeons, the competition between Metal and Ceramic is intensifying, with each material offering distinct advantages for specific patient needs and therapeutic strategies.

By Surgery Type: Total Hip Replacement (Largest) vs. Partial Hip Replacement (Fastest-Growing)

The hip reconstruction devices market is primarily dominated by Total Hip Replacement (THR), which has established itself as the largest segment in terms of volume and utilization. THR accounts for a significant portion of surgical procedures performed, reflecting growing patient demands and advancements in surgical techniques. Meanwhile, Partial Hip Replacement (PHR) is emerging as a rapidly growing segment, gaining traction among both patients and surgeons for its minimally invasive approach and quicker recovery times, contributing to its increasing acceptance in clinical practice.

Total Hip Replacement (Dominant) vs. Partial Hip Replacement (Emerging)

Total Hip Replacement (THR) represents the dominant segment in the hip reconstruction devices market, primarily favored for its effectiveness in treating advanced hip osteoarthritis and other degenerative conditions. It facilitates the complete removal of the damaged hip joint, ensuring improved patient mobility and quality of life. In contrast, Partial Hip Replacement (PHR) is gaining stature as an emerging alternative, particularly appealing for patients with specific fractures or non-arthritic conditions. While THR is extensively used in older adults, PHR is often preferred by younger patients seeking less invasive options, thus broadening its market appeal and paving the way for enhanced surgical technologies.

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Hip Reconstruction Devices Market, hospitals represent the largest segment, capturing a significant portion of the total market share. This dominance can be attributed to their extensive resources, advanced surgical facilities, and the increasing number of hip surgeries performed in these settings. Ambulatory surgical centers (ASCs) are also noteworthy as they are rapidly gaining traction, focusing on outpatient procedures, and providing cost-effective alternatives for hip reconstruction.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals are well-established in the Hip Reconstruction Devices Market, offering advanced surgical capabilities and comprehensive patient care. They possess extensive infrastructure and a wide range of surgical equipment, making them the preferred choice for complex hip reconstruction surgeries. Conversely, Ambulatory Surgical Centers are emerging as significant competitors, driven by the increasing demand for outpatient surgeries. ASCs streamline the surgical process, reducing recovery time and providing patients with a more convenient and cost-effective option for hip surgeries. This trend towards outpatient procedures is reshaping the landscape of hip reconstruction.

Get more detailed insights about Hip Reconstruction Devices Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for hip reconstruction devices, holding approximately 45% of the global market share. The region's growth is driven by an aging population, increasing prevalence of hip disorders, and advancements in surgical techniques. Regulatory support from agencies like the FDA further catalyzes innovation and market expansion, ensuring that new technologies are rapidly adopted to meet patient needs. The United States is the primary contributor to this market, with key players such as Stryker, DePuy Synthes, and Zimmer Biomet leading the competitive landscape. The presence of advanced healthcare infrastructure and high healthcare expenditure supports the growth of hip reconstruction devices. Additionally, ongoing research and development initiatives by these companies are expected to enhance product offerings and improve patient outcomes.

Europe : Emerging Market with Growth Potential

Europe is the second-largest market for hip reconstruction devices, accounting for approximately 30% of the global market share. The region's growth is fueled by increasing awareness of orthopedic health, rising geriatric population, and favorable reimbursement policies. Regulatory frameworks, such as the Medical Device Regulation (MDR), are also enhancing product safety and efficacy, thereby boosting market confidence and adoption rates. Leading countries in this region include Germany, France, and the UK, where companies like Smith & Nephew and B. Braun are prominent. The competitive landscape is characterized by a mix of established players and emerging startups, focusing on innovative solutions and minimally invasive techniques. The collaboration between healthcare providers and manufacturers is expected to drive further advancements in hip reconstruction technologies.

Asia-Pacific : Rapid Growth in Emerging Markets

Asia-Pacific is witnessing rapid growth in the hip reconstruction devices market, driven by increasing healthcare investments and a rising elderly population. The region holds approximately 20% of the global market share, with countries like China and India leading the charge. The demand for advanced medical technologies and improved healthcare infrastructure is propelling market expansion, supported by government initiatives aimed at enhancing healthcare access and quality. China is emerging as a significant player, with local manufacturers and international companies like Medtronic and Exactech expanding their presence. The competitive landscape is evolving, with a focus on affordability and accessibility of hip reconstruction devices. As healthcare systems in these countries continue to develop, the market is expected to grow significantly, driven by both public and private sector investments.

Middle East and Africa : Untapped Potential in Healthcare

The Middle East and Africa (MEA) region presents untapped potential in the hip reconstruction devices market, holding approximately 5% of the global market share. The growth is driven by increasing healthcare expenditure, rising awareness of orthopedic treatments, and government initiatives to improve healthcare infrastructure. The region's diverse demographics and varying healthcare needs create opportunities for market expansion, particularly in urban areas. Countries like South Africa and the UAE are leading the market, with a growing number of healthcare facilities and increasing access to advanced medical technologies. The competitive landscape is characterized by a mix of local and international players, focusing on affordability and quality. As healthcare systems evolve, the demand for hip reconstruction devices is expected to rise, supported by ongoing investments in healthcare infrastructure and services.

Hip Reconstruction Devices Market Regional Image

Key Players and Competitive Insights

The Hip Reconstruction Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements, an aging population, and increasing incidences of hip-related disorders. Major players such as Stryker (US), DePuy Synthes (US), and Zimmer Biomet (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Stryker (US) emphasizes innovation through continuous product development, while DePuy Synthes (US) focuses on strategic partnerships to expand its product offerings. Zimmer Biomet (US) appears to be concentrating on regional expansion, particularly in emerging markets, thereby shaping a competitive environment that is increasingly collaborative yet fiercely competitive.In terms of business tactics, companies are localizing manufacturing to reduce costs and enhance supply chain efficiency. The market structure is moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for niche players to thrive, yet the collective strength of the major companies drives innovation and sets high standards for quality and service.

In August Stryker (US) announced the launch of a new robotic-assisted surgical system designed specifically for hip reconstruction procedures. This strategic move is likely to enhance surgical precision and improve patient outcomes, thereby reinforcing Stryker's commitment to innovation in the orthopedic space. The introduction of this technology may also position Stryker as a leader in the growing trend of robotic-assisted surgeries, which are becoming increasingly popular in the medical field.

In September DePuy Synthes (US) entered into a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its hip reconstruction devices. This initiative appears to be a response to the rising demand for digital health solutions, allowing for better patient management and follow-up care. By leveraging telehealth, DePuy Synthes (US) may enhance patient engagement and satisfaction, potentially leading to improved clinical outcomes and a stronger market presence.

In July Zimmer Biomet (US) acquired a smaller firm specializing in advanced biomaterials for orthopedic applications. This acquisition seems to align with Zimmer Biomet's strategy to diversify its product portfolio and enhance its technological capabilities. By integrating these advanced materials into its hip reconstruction devices, the company could improve the performance and longevity of its products, thereby appealing to a broader customer base.

As of October the Hip Reconstruction Devices Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. The shift from price-based competition to a focus on innovation, technology, and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to deliver superior products and services that meet evolving patient needs.

Key Companies in the Hip Reconstruction Devices Market include

Industry Developments

Recent developments in the Global Hip Reconstruction Devices Market have seen significant advancements, particularly from key players such as Zimmer Biomet, Smith and Nephew, and DePuy Synthes. Innovations in product design and materials have led to enhanced surgical outcomes, increasing the demand for these devices. In terms of market activity, in June 2023, Stryker Corporation announced the expansion of its hip implant portfolio, further driving competition in the sector.

Additionally, in March 2023, Johnson and Johnson completed the acquisition of a smaller company specializing in orthopedic devices, aligning with its strategy to enhance its hip reconstruction offerings. The market is projected to witness substantial growth, with a valuation expected to exceed USD 15 billion by 2025, driven by an aging population and rising incidences of hip-related disorders.

Furthermore, the last few years have seen significant trends, such as the shift towards minimally invasive surgeries and the integration of smart technologies into hip reconstruction devices. The focus on improving recovery times and patient outcomes continues to shape the market landscape, pushing manufacturers to invest in Research and Development initiatives aimed at innovative and effective solutions.

Future Outlook

Hip Reconstruction Devices Market Future Outlook

The Hip Reconstruction Devices Market is projected to grow at a 7.0% CAGR from 2025 to 2035, driven by technological advancements, increasing geriatric population, and rising prevalence of hip disorders.

New opportunities lie in:

  • Development of personalized implant solutions using 3D printing technology.
  • Expansion into emerging markets with tailored pricing strategies.
  • Integration of telemedicine for post-operative monitoring and support.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.

Market Segmentation

Hip Reconstruction Devices Market Type Outlook

  • Hip Implants
  • Hip Resurfacing Devices
  • Orthopedic Surgical Instruments
  • Bone Cement

Hip Reconstruction Devices Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopedic Clinics

Hip Reconstruction Devices Market Material Outlook

  • Metal
  • Ceramic
  • Polyethylene
  • Composites

Hip Reconstruction Devices Market Surgery Type Outlook

  • Total Hip Replacement
  • Partial Hip Replacement
  • Hip Revision Surgery

Report Scope

MARKET SIZE 2024 9.188(USD Billion)
MARKET SIZE 2025 9.832(USD Billion)
MARKET SIZE 2035 19.34(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.0% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Stryker (US), DePuy Synthes (US), Zimmer Biomet (US), Smith & Nephew (GB), Medtronic (US), B. Braun (DE), Exactech (US), Aesculap (DE), Wright Medical Group (US)
Segments Covered Product Type, Material, Surgery Type, End Users, Regional
Key Market Opportunities Integration of advanced materials and robotics enhances outcomes in the Hip Reconstruction Devices Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the Hip Reconstruction Devices Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Hip Reconstruction Devices Market by 2035?

The Hip Reconstruction Devices Market is projected to reach a valuation of 19.34 USD Billion by 2035.

What was the market valuation of the Hip Reconstruction Devices Market in 2024?

In 2024, the market valuation of the Hip Reconstruction Devices Market was 9.188 USD Billion.

What is the expected CAGR for the Hip Reconstruction Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Hip Reconstruction Devices Market during the forecast period 2025 - 2035 is 7.0%.

Which companies are considered key players in the Hip Reconstruction Devices Market?

Key players in the Hip Reconstruction Devices Market include Stryker, DePuy Synthes, Zimmer Biomet, Smith & Nephew, Medtronic, B. Braun, Exactech, Aesculap, and Wright Medical Group.

What are the main segments of the Hip Reconstruction Devices Market?

The main segments of the Hip Reconstruction Devices Market include Type, Material, Surgery Type, and End User.

What was the valuation of Hip Implants in 2024?

In 2024, the valuation of Hip Implants was 3.5 USD Billion.

How much is the Hip Resurfacing Devices segment expected to grow by 2035?

The Hip Resurfacing Devices segment is expected to grow to 4.0 USD Billion by 2035.

What is the projected valuation for Bone Cement by 2035?

The projected valuation for Bone Cement is expected to reach 3.34 USD Billion by 2035.

Which end user segment had a valuation of 3.688 USD Billion in 2024?

The Orthopedic Clinics end user segment had a valuation of 3.688 USD Billion in 2024.

What is the expected growth for Total Hip Replacement surgeries by 2035?

Total Hip Replacement surgeries are projected to grow to 11.5 USD Billion by 2035.

Author
Author
Author Profile
Vikita Thakur LinkedIn
Senior Research Analyst
She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

Research Approach

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) 510(k) Premarket Notification Database and PMA Approvals, European Medicines Agency (EMA) Medical Device Regulation (MDR) Database, National Institutes of Health (NIH) National Library of Medicine (PubMed/MEDLINE), National Center for Biotechnology Information (NCBI), Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS) National Hospital Discharge Survey, Agency for Healthcare Research and Quality (AHRQ) Healthcare Cost and Utilization Project (HCUP), World Health Organization (WHO) Global Health Observatory, Organisation for Economic Co-operation and Development (OECD) Health Statistics, American Academy of Orthopaedic Surgeons (AAOS) National Joint Registry (NJR) Data, American Association of Hip and Knee Surgeons (AAHKS) Registry Data, International Society of Arthroplasty Registries (ISAR), EU Eurostat Health Database, National Institute for Health and Care Excellence (NICE) UK, Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), Canadian Institute for Health Information (CIHI) Discharge Abstract Database, Japan Ministry of Health, Labour and Welfare (MHLW) Medical Device Registration Database, China National Medical Products Administration (NMPA) Medical Device Database, and national health ministry reports from key markets. These sources were used to collect procedure statistics, regulatory approval data, clinical safety studies, implant survivorship data, demographic trends, and market landscape analysis for primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices, hip resurfacing devices, dual-mobility systems, and modular neck/stem components across cemented, cementless, and hybrid fixation types.

Specific Regulatory & Clinical Sources:

FDA CDRH 510(k) Database (Orthopedic Devices Branch)

FDA PMA Database (Class III Orthopedic Implants)

EUDAMED (European Database on Medical Devices)

Australian Therapeutic Goods Administration (TGA) ARTG

Health Canada Medical Devices Active Licence Listing (MDALL)

PMDA Japan Medical Device NDB Database

NMPA China Medical Device Registration Database

AAOS Orthopaedic Research and Education Foundation (OREF) Data

International Consortium of Orthopaedic Registries (ICOR)

National Joint Registry (NJR) for England, Wales, Northern Ireland and Isle of Man

Swedish Hip Arthroplasty Register

Finnish Arthroplasty Register

Norwegian Arthroplasty Register

Danish Hip Arthroplasty Register

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consisted of CEOs, VPs of Product Development, Chief Technology Officers, regulatory affairs heads, quality assurance directors, manufacturing operations heads, supply chain directors, and commercial directors from hip reconstruction device manufacturers, OEMs, and contract manufacturers. Demand-side sources included hip and knee specialists who were board-certified orthopedic surgeons, chiefs of orthopedic surgery departments, hospital procurement directors, materials management directors, orthopedic clinic medical directors, ambulatory surgical center administrators, value analysis committees, and group purchasing organization (GPO) representatives. The market segmentation was validated by primary research across product types (primary/partial/revision/resurfacing/dual-mobility), fixation techniques (cemented/cementless/hybrid), bearing surfaces (metal-on-polyethylene/ceramic-on-polyethylene/ceramic-on-ceramic/metal-on-metal), and end-user settings (hospitals/orthopedic clinics/ASCs). Additionally, the product pipeline timelines for 3D-printed implants and robotic-assisted technologies were confirmed, and insights on clinical adoption patterns, pricing strategies, bundled payment models, and reimbursement dynamics were gathered.

Primary Respondent Breakdown:

By Designation: C-level Primaries (28%), Director Level (32%), Others (40%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Market Size Estimation

Global market valuation was derived through revenue mapping and procedure volume analysis. The methodology included:

Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Product mapping across primary hip reconstruction devices, partial hip reconstruction devices, revision devices, hip resurfacing devices, dual-mobility systems, and modular neck/stem components

Material segmentation analysis across metal-on-polyethylene, ceramic-on-polyethylene, ceramic-on-ceramic, ceramic-on-metal, and metal-on-metal bearing surfaces

Fixation type analysis across cemented, cementless (press-fit), and hybrid fixation systems

Analysis of reported and modeled annual revenues specific to hip reconstruction portfolios

Coverage of manufacturers representing 75-80% of global market share in 2024

Extrapolation using bottom-up (procedure volume × ASP by country/region) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.